share_log
Reuters ·  May 8 08:30
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of Nbi-1117567 in Healthy Adults
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment